ISPOR - PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES

Full Text

PIN10 A COST CONSEQUENCE ON CONCOMITANT DRUG USE DURING HCV THERAPY IN MANAGED CARE PATIENTS IN THE UNITED STATES

Abstract

Authors

TK Le H Yu

Back to Volume 6, Issue 6

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now